Jan 11, 2024 8:15 am - 8:55 am PST Adrian Rawcliffe, Adaptimmune CEO, presents at JP Morgan Healthcare Conference 2024
Mar 8, 2023 2:10 pm - 3:10 pm EST Adaptimmune to Participate in the Cowen Health Care Conference Cell Therapy Panel
May 11, 2021 8:00 am - 10:00 am EDT Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
Mar 4, 2020 10:40 am EST Cowen And Company's 40th Annual Health Care Conference At Boston Marriot Copley Place
May 2, 2019 11:30 am EDT Differentiating T-Cells From HiPSCs To Create Off-The-Shelf SPEAR T-Cell Therapies
Feb 14, 2019 10:00 am EST Guggenheim Healthcare Talks Idea Forum Oncology Day Adaptimmune Therapeutics
Apr 17, 2018 11:40 am EDT The 6th Annual Alliance For Regenerative Medicine (ARM) Cell & Gene Therapy Investor Day
Dec 11, 2017 5:30 pm EST American Society Of Hematology (ASH) Annual Meeting Confirm NY-ESO SPEAR T-Cell Efficacy In Multiple Myeloma Pilot Study
Jun 6, 2017 8:00 am EDT Adaptimmune Data Update On NY-ESO SPEAR T-Cells In Synovial Sarcoma; ASCO 2017
Feb 2, 2016 10:00 am EST Adaptimmune To Discuss Expansion Of Strategic Collaboration Agreement With GlaxoSmithKline (GSK)